---
title: "Remote Monitoring for Heart Failure: Evidence — Vironix"
description: "Compare heart-failure monitoring trials and reviews, including neutral results, hospitalization outcomes and uncertainty about mortality."
image: "https://www.vironix.ai/_astro/open_graph_vironix.uvCNQF08_27tYOt.webp"
canonical: "https://www.vironix.ai/research/guides/heart-failure-hospitalizations"
source: "https://www.vironix.ai/research/guides/heart-failure-hospitalizations"
---

<!-- Generated from https://www.vironix.ai/research/guides/heart-failure-hospitalizations. Do not edit this file directly. -->

[Home](https://www.vironix.ai/index.md) [Research & Evidence](https://www.vironix.ai/research.md) Does remote patient monitoring reduce heart failure hospitalizations?

Evidence guide

# Does remote patient monitoring reduce heart failure hospitalizations?

Pooled evidence favors fewer heart-failure hospitalizations with home monitoring. Non-invasive monitoring was associated with 22% lower odds of a first heart-failure hospitalization, and a broader 2026 review reached a similar, low-certainty estimate. Results for all-cause hospital use and some individual trials are more mixed, so this guide shows which outcomes improved and what care accompanied the monitoring.

Summary by Vironix Health · Source review: November 12, 2026  
[How we select and interpret evidence](https://www.vironix.ai/research/methodology.md)

Curation cutoff: November 11, 2026

## What to take away

-   Non-invasive monitoring was associated with 22% lower odds of a first heart-failure hospitalization (OR 0.78, 95% CI 0.70–0.87).
-   All-cause hospitalization and some individual trials, including OSICAT, did not show a clear benefit; choose the target outcome before measuring a program.
-   The programs studied paired monitoring with education, communication and clinical follow-up. Plan for that care, not just the device.

## Compare the outcomes before comparing programs

Selected results below use different effect measures and endpoints. Read the source summaries for the methods; reviews may include the same trials.

| 
Evidence

 | 

Result to keep in view

 | 

Limit on applying it

 |
| --- | --- | --- |
| 

[De Lathauwer review](https://www.vironix.ai/research/studies/heart-failure-rpm-components.md) · non-invasive monitoring

 | 

First HF hospitalization: OR 0.78 (95% CI 0.70–0.87). All-cause hospitalization: OR 0.90 (0.78–1.05).

 | 

The broader hospitalization result was inconclusive. Components were not randomized separately.

 |
| 

[Muller Ferreira and Muller review](https://www.vironix.ai/research/studies/heart-failure-rpm-trial-sequential-review.md) · broader monitoring approaches

 | 

HF hospitalization: RR 0.781 (95% CI 0.710–0.859), low certainty.

 | 

Includes telephone and implanted-device monitoring; the prediction interval crossed no effect.

 |
| 

[OSICAT trial](https://www.vironix.ai/research/studies/osicat-heart-failure-trial.md) · daily weight/symptoms and education

 | 

Primary composite of all-cause death or unplanned hospitalization events: rate ratio 0.97 (95% CI 0.77–1.23).

 | 

Neutral primary result; post-randomization exclusions and incomplete follow-up complicate interpretation.

 |

Supporting studies: [Ignace L J De Lathauwer (2025) \[1\]](https://www.vironix.ai/research/studies/heart-failure-rpm-components.md); [Vicky Muller Ferreira (2026) \[2\]](https://www.vironix.ai/research/studies/heart-failure-rpm-trial-sequential-review.md); [Michel Galinier (2020) \[3\]](https://www.vironix.ai/research/studies/osicat-heart-failure-trial.md)

## Which outcomes improved—and which did not

De Lathauwer’s non-invasive monitoring review favored first HF hospitalization and mortality. Its all-cause hospitalization estimate did not exclude no effect (OR 0.90, 95% CI 0.78–1.05). This difference matters when deciding what a service is expected to change.

Supporting studies: [Ignace L J De Lathauwer (2025) \[1\]](https://www.vironix.ai/research/studies/heart-failure-rpm-components.md)

## What the earlier telehealth review adds

Masotta’s review pooled only 17 of 61 included studies and searched through August 2021. Favorable one-year results coexist with mixed narrative findings, high heterogeneity and nonrandomized evidence. Its implanted-device, telephone and other monitoring programs are broader than routine non-invasive RPM. Reviews sharing trials are not independent replications.

Supporting studies: [Vittorio Masotta (2024) \[4\]](https://www.vironix.ai/research/studies/heart-failure-telehealth-masotta-review.md)

## What the 2026 review adds

Muller Ferreira and Muller reviewed 65 studies, with 59 trials poolable. Unlike the non-invasive review above, this synthesis also covers telephone support and invasive/implanted-device monitoring. HF hospitalization favored monitoring (RR 0.781, 95% CI 0.710–0.859; low certainty), but all-cause hospitalization did not clearly improve. Mortality favored monitoring in the main analysis (RR 0.911, 95% CI 0.842–0.985; moderate certainty); a publication-bias sensitivity analysis crossed no effect. The HF hospitalization prediction interval also crossed no effect, so the pooled average does not imply benefit in every setting.

Supporting studies: [Vicky Muller Ferreira (2026) \[2\]](https://www.vironix.ai/research/studies/heart-failure-rpm-trial-sequential-review.md); [Ignace L J De Lathauwer (2025) \[1\]](https://www.vironix.ai/research/studies/heart-failure-rpm-components.md)

## What care accompanied the monitoring?

De Lathauwer’s review compares programs with varying communication, education and self-management support. Such activities can overlap with the work of a CCM team, but the review is not a direct test of formal RPM+CCM versus RPM alone. Exploratory comparisons between program components cannot isolate the effect of adding CCM.

Check which care activities the publication reports, who performed them and how they connect with treatment. If an activity is not reported, record that uncertainty rather than assuming the activity was absent. A trial of a narrower care package does not evaluate every part of a combined service.

Supporting studies: [Ignace L J De Lathauwer (2025) \[1\]](https://www.vironix.ai/research/studies/heart-failure-rpm-components.md); [Michel Galinier (2020) \[3\]](https://www.vironix.ai/research/studies/osicat-heart-failure-trial.md)

## Why neutral trials belong in the guide

OSICAT did not improve its primary composite endpoint. Its intervention included daily weight and symptom monitoring plus education, so it should not be described as device-only care. More favorable adjusted secondary or subgroup analyses do not replace the neutral primary result. Differences from a proposed combined program matter, but they do not establish that missing CCM caused the neutral result.

Supporting studies: [Michel Galinier (2020) \[3\]](https://www.vironix.ai/research/studies/osicat-heart-failure-trial.md); [Ignace L J De Lathauwer (2025) \[1\]](https://www.vironix.ai/research/studies/heart-failure-rpm-components.md)

## Keep the outcome definitions visible

The broad utilization synthesis also distinguishes the proportion hospitalized, admission counts and length of stay. Those measures answer different questions. Our recommendation is to choose the intended endpoint before measuring a local program and to report the comparison and follow-up period.

Supporting studies: [Geir Smedslund (2025) \[5\]](https://www.vironix.ai/research/studies/rpm-health-care-utilization.md)

## Evidence gaps

Trials vary in patient risk, usual care, follow-up and the clinical response to monitoring. The 2025 and 2026 reviews share underlying trials; do not add their participant counts or treat them as independent replications. The newer review includes broader monitoring approaches and no exclusively preserved-ejection-fraction population among its pooled trials. Exploratory component comparisons do not prove that a particular component caused benefit. These summaries do not establish which program is best for a particular patient.

## Practical interpretation

For a practice considering managed heart-failure RPM, use these findings to discuss the patient population and intended outcomes with the service partner. Distinguish HF admissions, all-cause hospital use and other outcomes, with a defined comparator and follow-up period.

-   Agree how the monitoring team connects concerning readings with the appropriate clinician.
-   Clarify staffed coverage, after-hours patient instructions and follow-up across the care team.
-   Review participation, withdrawals, missing readings and hospital events alongside favorable trends; changes in case mix can change apparent results.

The [care-team workflow guide](https://www.vironix.ai/research/guides/care-team-workflows.md) explains how a managed service can coordinate these activities with the practice. See [Vironix RPM services](https://www.vironix.ai/rpm.md) for the operating model. The studies describe their own populations and interventions; Vironix program results are presented separately on the service page.

Vironix’s risk models build on peer-reviewed work, including a machine-learning method for identifying and triaging heart-failure exacerbations (Journal of Cardiovascular Translational Research, 2022). See [Vironix science and publications](https://www.vironix.ai/science.md).

## References

1.  [Remote patient monitoring in heart failure: A comprehensive meta-analysis of effective programme components for hospitalization and mortality reduction](https://www.vironix.ai/research/studies/heart-failure-rpm-components.md)
    
    Ignace L J De Lathauwer; Wessel W Nieuwenhuys; Frederique Hafkamp; Marta Regis; Rutger W M Brouwers; Mathias Funk; Hareld M C Kemps. European Journal of Heart Failure. 2025.
    
    [Original source](https://onlinelibrary.wiley.com/doi/full/10.1002/ejhf.3568)
2.  [Remote Patient Monitoring in Heart Failure: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis](https://www.vironix.ai/research/studies/heart-failure-rpm-trial-sequential-review.md)
    
    Vicky Muller Ferreira; Victor Ayres Muller. Cureus. 2026.
    
    [Original source](https://doi.org/10.7759/cureus.109198)
3.  [Telemonitoring versus standard care in heart failure: a randomised multicentre trial](https://www.vironix.ai/research/studies/osicat-heart-failure-trial.md)
    
    Michel Galinier; François Roubille; Philippe Berdague; Gilles Brierre; Philippe Cantie; Patrick Dary; Jean-Marc Ferradou; Olivier Fondard; Jean Philippe Labarre; Jacques Mansourati; François Picard; Jean-Etienne Ricci; Muriel Salvat; Lamia Tartière; Jean-Bernard Ruidavets; Vanina Bongard; Cécile Delval; Guila Lancman; Hélène Pasche; Juan Fernando Ramirez-Gil; Atul Pathak; OSICAT Investigators. European Journal of Heart Failure. 2020.
    
    [Original source](https://onlinelibrary.wiley.com/doi/full/10.1002/ejhf.1906)
4.  [Telehealth care and remote monitoring strategies in heart failure patients: A systematic review and meta-analysis](https://www.vironix.ai/research/studies/heart-failure-telehealth-masotta-review.md)
    
    Vittorio Masotta; Angelo Dante; Valeria Caponnetto; Alessia Marcotullio; Fabio Ferraiuolo; Luca Bertocchi; Francesco Camero; Loreto Lancia; Cristina Petrucci. Heart & Lung. 2024.
    
    [Original source](https://doi.org/10.1016/j.hrtlng.2024.01.003)
5.  [Effects of Remote Patient Monitoring on Health Care Utilization in Patients With Noncommunicable Diseases: Systematic Review and Meta-Analysis](https://www.vironix.ai/research/studies/rpm-health-care-utilization.md)
    
    Geir Smedslund; Nina Østerås; Christine Hillestad Hestevik. JMIR mHealth and uHealth. 2025.
    
    [Original source](https://mhealth.jmir.org/2025/1/e68464)

Explore Vironix services: [RPM](https://www.vironix.ai/rpm.md) · [CCM](https://www.vironix.ai/ccm.md)

```json
{
  "@context": "https://schema.org",
  "@type": "Organization",
  "@id": "https://www.vironix.ai/#organization",
  "name": "Vironix Health",
  "alternateName": "Vironix",
  "url": "https://www.vironix.ai",
  "logo": "https://www.vironix.ai/_astro/Vironix_Logo_Primary_300.CFX8xheF.png",
  "description": "Vironix is a digital health platform that enables healthcare providers to provide AI-enabled virtual care services to their patients, including remote patient monitoring, chronic care management, remote therapeutic monitoring, and more.",
  "sameAs": [
    "https://www.linkedin.com/company/vironix-health"
  ]
}
{
  "@context": "https://schema.org",
  "@type": "WebSite",
  "@id": "https://www.vironix.ai/#website",
  "url": "https://www.vironix.ai",
  "name": "Vironix Health",
  "publisher": {
    "@id": "https://www.vironix.ai/#organization"
  },
  "inLanguage": "en-US"
}
{
  "@context": "https://schema.org",
  "@type": "BreadcrumbList",
  "itemListElement": [
    {
      "@type": "ListItem",
      "position": 1,
      "name": "Home",
      "item": "https://www.vironix.ai/"
    },
    {
      "@type": "ListItem",
      "position": 2,
      "name": "Research & Evidence",
      "item": "https://www.vironix.ai/research"
    },
    {
      "@type": "ListItem",
      "position": 3,
      "name": "Does remote patient monitoring reduce heart failure hospitalizations?",
      "item": "https://www.vironix.ai/research/guides/heart-failure-hospitalizations.html"
    }
  ]
}
{
  "@context": "https://schema.org",
  "@type": "Article",
  "@id": "https://www.vironix.ai/research/guides/heart-failure-hospitalizations#article",
  "headline": "Does remote patient monitoring reduce heart failure hospitalizations?",
  "description": "Compare heart-failure monitoring trials and reviews, including neutral results, hospitalization outcomes and uncertainty about mortality.",
  "url": "https://www.vironix.ai/research/guides/heart-failure-hospitalizations",
  "mainEntityOfPage": "https://www.vironix.ai/research/guides/heart-failure-hospitalizations",
  "inLanguage": "en-US",
  "articleSection": "Research & Evidence",
  "isPartOf": {
    "@id": "https://www.vironix.ai/research"
  },
  "datePublished": "2026-11-16T16:44:24.827Z",
  "dateModified": "2026-11-16T16:44:24.835Z",
  "author": {
    "@type": "Organization",
    "name": "Vironix Health",
    "@id": "https://www.vironix.ai/#organization",
    "url": "https://www.vironix.ai/about"
  },
  "publisher": {
    "@id": "https://www.vironix.ai/#organization"
  },
  "citation": [
    {
      "@type": "ScholarlyArticle",
      "@id": "https://doi.org/10.1002/ejhf.3568",
      "name": "Remote patient monitoring in heart failure: A comprehensive meta-analysis of effective programme components for hospitalization and mortality reduction",
      "author": [
        {
          "@type": "Person",
          "name": "Ignace L J De Lathauwer"
        },
        {
          "@type": "Person",
          "name": "Wessel W Nieuwenhuys"
        },
        {
          "@type": "Person",
          "name": "Frederique Hafkamp"
        },
        {
          "@type": "Person",
          "name": "Marta Regis"
        },
        {
          "@type": "Person",
          "name": "Rutger W M Brouwers"
        },
        {
          "@type": "Person",
          "name": "Mathias Funk"
        },
        {
          "@type": "Person",
          "name": "Hareld M C Kemps"
        }
      ],
      "datePublished": "2025-01-20",
      "url": "https://onlinelibrary.wiley.com/doi/full/10.1002/ejhf.3568",
      "identifier": "10.1002/ejhf.3568",
      "isPartOf": {
        "@type": "Periodical",
        "name": "European Journal of Heart Failure"
      }
    },
    {
      "@type": "ScholarlyArticle",
      "@id": "https://doi.org/10.7759/cureus.109198",
      "name": "Remote Patient Monitoring in Heart Failure: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis",
      "author": [
        {
          "@type": "Person",
          "name": "Vicky Muller Ferreira"
        },
        {
          "@type": "Person",
          "name": "Victor Ayres Muller"
        }
      ],
      "datePublished": "2026-05-19",
      "url": "https://doi.org/10.7759/cureus.109198",
      "identifier": "10.7759/cureus.109198",
      "isPartOf": {
        "@type": "Periodical",
        "name": "Cureus"
      }
    },
    {
      "@type": "ScholarlyArticle",
      "@id": "https://doi.org/10.1002/ejhf.1906",
      "name": "Telemonitoring versus standard care in heart failure: a randomised multicentre trial",
      "author": [
        {
          "@type": "Person",
          "name": "Michel Galinier"
        },
        {
          "@type": "Person",
          "name": "François Roubille"
        },
        {
          "@type": "Person",
          "name": "Philippe Berdague"
        },
        {
          "@type": "Person",
          "name": "Gilles Brierre"
        },
        {
          "@type": "Person",
          "name": "Philippe Cantie"
        },
        {
          "@type": "Person",
          "name": "Patrick Dary"
        },
        {
          "@type": "Person",
          "name": "Jean-Marc Ferradou"
        },
        {
          "@type": "Person",
          "name": "Olivier Fondard"
        },
        {
          "@type": "Person",
          "name": "Jean Philippe Labarre"
        },
        {
          "@type": "Person",
          "name": "Jacques Mansourati"
        },
        {
          "@type": "Person",
          "name": "François Picard"
        },
        {
          "@type": "Person",
          "name": "Jean-Etienne Ricci"
        },
        {
          "@type": "Person",
          "name": "Muriel Salvat"
        },
        {
          "@type": "Person",
          "name": "Lamia Tartière"
        },
        {
          "@type": "Person",
          "name": "Jean-Bernard Ruidavets"
        },
        {
          "@type": "Person",
          "name": "Vanina Bongard"
        },
        {
          "@type": "Person",
          "name": "Cécile Delval"
        },
        {
          "@type": "Person",
          "name": "Guila Lancman"
        },
        {
          "@type": "Person",
          "name": "Hélène Pasche"
        },
        {
          "@type": "Person",
          "name": "Juan Fernando Ramirez-Gil"
        },
        {
          "@type": "Person",
          "name": "Atul Pathak"
        },
        {
          "@type": "Organization",
          "name": "OSICAT Investigators"
        }
      ],
      "datePublished": "2020-05-21",
      "url": "https://onlinelibrary.wiley.com/doi/full/10.1002/ejhf.1906",
      "identifier": "10.1002/ejhf.1906",
      "isPartOf": {
        "@type": "Periodical",
        "name": "European Journal of Heart Failure"
      }
    },
    {
      "@type": "ScholarlyArticle",
      "@id": "https://doi.org/10.1016/j.hrtlng.2024.01.003",
      "name": "Telehealth care and remote monitoring strategies in heart failure patients: A systematic review and meta-analysis",
      "author": [
        {
          "@type": "Person",
          "name": "Vittorio Masotta"
        },
        {
          "@type": "Person",
          "name": "Angelo Dante"
        },
        {
          "@type": "Person",
          "name": "Valeria Caponnetto"
        },
        {
          "@type": "Person",
          "name": "Alessia Marcotullio"
        },
        {
          "@type": "Person",
          "name": "Fabio Ferraiuolo"
        },
        {
          "@type": "Person",
          "name": "Luca Bertocchi"
        },
        {
          "@type": "Person",
          "name": "Francesco Camero"
        },
        {
          "@type": "Person",
          "name": "Loreto Lancia"
        },
        {
          "@type": "Person",
          "name": "Cristina Petrucci"
        }
      ],
      "datePublished": "2024-01-18",
      "url": "https://doi.org/10.1016/j.hrtlng.2024.01.003",
      "identifier": "10.1016/j.hrtlng.2024.01.003",
      "isPartOf": {
        "@type": "Periodical",
        "name": "Heart & Lung"
      }
    },
    {
      "@type": "ScholarlyArticle",
      "@id": "https://doi.org/10.2196/68464",
      "name": "Effects of Remote Patient Monitoring on Health Care Utilization in Patients With Noncommunicable Diseases: Systematic Review and Meta-Analysis",
      "author": [
        {
          "@type": "Person",
          "name": "Geir Smedslund"
        },
        {
          "@type": "Person",
          "name": "Nina Østerås"
        },
        {
          "@type": "Person",
          "name": "Christine Hillestad Hestevik"
        }
      ],
      "datePublished": "2025-10-01",
      "url": "https://mhealth.jmir.org/2025/1/e68464",
      "identifier": "10.2196/68464",
      "isPartOf": {
        "@type": "Periodical",
        "name": "JMIR mHealth and uHealth"
      }
    }
  ]
}
```
